LGLFX | Growth Leaders Fund Class F | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Growth Leaders Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Growth Leaders Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of U.S. companies.

Fund Basicsas of 05/31/2022

Total Net Assets
$6.37 B
Inception Date
06/30/2011
Dividend Frequency
Annually
Fund Gross Expense Ratio
0.74%
Fund Net Expense Ratio
0.64%
Number of Holdings
55
 
 

Fund Expense Ratio :

Gross 0.74%

Net 0.64%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 06/30/2011
w/o sales charge -27.99% -19.29% 16.06% 16.28% 16.06% 14.38%
Lipper Category Avg. Multi-Cap Growth Funds -26.46% -19.16% 11.53% 11.85% 12.86% -
Russell 1000® Growth Index -21.88% -6.25% 18.31% 16.13% 16.06% 14.92%

Fund Expense Ratio :

Gross 0.74%

Net 0.64%

Fund Expense Ratio :

Gross 0.74%

Net 0.64%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 06/30/2011
w/o sales charge -13.04% -1.51% 23.41% 22.39% 17.32% 16.65%
Lipper Category Avg. Multi-Cap Growth Funds -12.54% -0.08% 17.70% 17.01% 13.89% -
Russell 1000® Growth Index -9.04% 14.98% 23.60% 20.88% 17.04% 16.81%

Fund Expense Ratio :

Gross 0.74%

Net 0.64%

RELATED CONTENT

Equities: Identifying Potential Inflation Winners and Losers
December 7, 2021

We believe investors should focus on the stocks of four types of companies that may be best- positioned to prosper during a sustained period of rising prices.

TEN LARGEST HOLDINGS as of 05/31/2022View Portfolio

Holding Assets
Microsoft Corp 10.3%
Apple Inc 9.0%
Alphabet Inc 7.7%
Tesla Inc 4.5%
Mastercard Inc 2.8%
Cheniere Energy Inc 2.7%
NVIDIA Corp 2.4%
Monolithic Power Systems Inc 2.3%
Amazon.com Inc 2.2%
Vertex Pharmaceuticals Inc 2.1%

INVESTMENT TEAM

F. Thomas O'Halloran
F. Thomas O'Halloran, CFA, J.D.

Partner & Portfolio Manager

35 Years of Industry Experience

Vernon Bice
Vernon Bice, CMT

Portfolio Manager

21 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner & Director of Equities

21 Years of Industry Experience

Supported By 41 Investment Professionals with 19 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 0.74%

Net 0.64%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 06/30/2011
w/o sales charge -27.99% -19.29% 16.06% 16.28% 16.06% 14.38%
Lipper Category Avg. Multi-Cap Growth Funds -26.46% -19.16% 11.53% 11.85% 12.86% -
Russell 1000® Growth Index -21.88% -6.25% 18.31% 16.13% 16.06% 14.92%

Fund Expense Ratio :

Gross 0.74%

Net 0.64%

Fund Expense Ratio :

Gross 0.74%

Net 0.64%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 06/30/2011
w/o sales charge -13.04% -1.51% 23.41% 22.39% 17.32% 16.65%
Lipper Category Avg. Multi-Cap Growth Funds -12.54% -0.08% 17.70% 17.01% 13.89% -
Russell 1000® Growth Index -9.04% 14.98% 23.60% 20.88% 17.04% 16.81%

Fund Expense Ratio :

Gross 0.74%

Net 0.64%

Year Fund Returns Russell 1000® Growth Index
2021 8.95% 27.60%
2020 77.44% 38.49%
2019 35.09% 36.39%
2018 -0.68% -1.51%
2017 31.52% 30.21%
2016 0.71% 7.08%
2015 6.83% 5.67%
2014 10.33% 13.05%
2013 47.03% 33.48%
2012 10.30% 15.26%
2011 -8.27% -
Year Q1 Q2 Q3 Q4 Yearly Returns
2022 -13.04% - - - -30.25%
2021 -3.80% 6.55% 1.54% 4.68% 8.95%
2020 -9.74% 40.21% 18.95% 17.88% 77.44%
2019 20.83% 6.35% -5.90% 11.72% 35.09%
2018 4.65% 6.99% 11.07% -20.14% -0.68%
2017 8.03% 6.21% 6.57% 7.55% 31.52%
2016 -3.93% 0.74% 6.07% -1.89% 0.71%
2015 4.73% 1.20% -6.12% 7.36% 6.83%
2014 2.11% 3.63% 0.03% 4.24% 10.33%
2013 11.46% 7.26% 13.21% 8.64% 47.03%
2012 15.55% -5.84% 3.92% -2.45% 10.30%
2011 - - -14.97% 7.89% -8.27%

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 3/31/2022

  • As we enter the second quarter of 2022, it appears more and more likely that the 2020s are becoming a decade of discord rather than another “roaring 20s” that many commentators had forecast a couple of years ago.  Between continued headwinds stemming from COVID-19, sustained inflation, policy regime changes by the U.S. Federal Reserve (Fed), and, more recently, Russia’s shockingly barbaric and tragic aggression on Ukraine, the era of democratization, disinflation, globalization, and declining conflict of 1989-2019 is, at best, on pause.  However, we maintain that the technology revolution will power ahead despite all the tumult around the world, and that the secular growth leaders should generally distinguish themselves from the broader equity market with outsized returns throughout this decade. The fact that many great names have sold off during this bear market and now appear severely oversold only strengthens that case and argues for rebalancing into beaten down innovation stocks within a broader asset allocation.
  • We continue to focus on finding great businesses with both strong operating momentum and resilient stock price momentum to navigate this hostile environment.  We are also looking to balance the risks of disparate, highly consequential potential outcomes to global concerns today, between the global growth risks of a worsening war narrative, to the potential for peace to break out, to the inflationary pressures of economic reopening 2.0, to the risks of a Fed blunder. These can all have varying impacts on different segments of the market and betting on one over the others may create unnecessary risks for investors. That said, our goal in the near term is to preserve the significant excess returns from 2017-2020, keep our clients invested to potentially benefit from the ensuing bull market in innovation, and deliver on our mandate as growth investors.
  • We are now at the low end of our holdings range, which in this strategy is a sign of defensiveness. It means that fewer companies are meeting our criteria of being an innovator and superior business with strong operating momentum and positive price momentum. It also means we are gravitating more towards larger and megacap names that have served as portfolio stabilizers in recent years, even though their organic growth has slowed from what it once was. Additionally, a greater percentage of the portfolio is in stocks we would likely not own in a more positive environment, in that they are less-dynamic innovators, have lower Research & Development investment, and have lower intrinsic volatility with more predictability around earnings in the near term.

PORTFOLIO DETAILS as of 05/31/2022

Total Net Assets
$6.37 B
Number of Holdings
55
Weighted Average Market Cap.
723.7 B
P/B Ratio
9.9x
P/E Ratio
29.3x

Contributors & Detractors as of  03/31/2022

Contributors

Holding Contribution
Vertex Pharmaceuticals Inc 0.2%
Deere & Co. 0.2%
Palo Alto Networks Inc 0.1%
American Express Co. 0.1%
Cheniere Energy Inc 0.1%

Detractors

Holding Contribution
EPAM Systems Inc -1.1%
Microsoft Corp. -0.7%
Advanced Micro Devices, Inc. -0.6%
Intuit Inc -0.5%
Mongodb Inc -0.4%

Attribution Analysis 

Growth Leaders Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 06/24/2022
$0
Dividend Frequency
Annually
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
12/27/2012 12/28/2012 12/28/2012 $0.03120 $15.17
11/19/2012 11/20/2012 11/20/2012 $0.04720 $14.96

Upcoming Dividend Payment Dates

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
11/21/2022 11/22/2022 11/22/2022

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
11/22/2021 11/23/2021 $6.5143 $3.4867 $10.0010 $44.15

Upcoming Capital Gain Distribution

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
11/21/2022 11/22/2022

Fees & Expenses

Fees & Expenses

EXPENSE RATIOas of 05/31/2022

Fund Gross Expense Ratio Fund Net Expense Ratio
0.74% 0.64%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015
Fund Story
Publish Date:11/03/2015
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field